Skip to main content
. Author manuscript; available in PMC: 2012 Feb 15.
Published in final edited form as: Clin Cancer Res. 2010 Nov 24;17(4):896–906. doi: 10.1158/1078-0432.CCR-10-2463

Figure 1. Patient outcomes.

Figure 1

Figure 1

Figure 1

Figure 1

A, Kaplan-Meier relapse-free survival curve for all patients treated with ipilimumab. B, Kaplan-Meier overall survival curve for all patients treated with ipilimumab. C, Kaplan-Meier relapse-free survival curves comparing Stage IIIc patients (solid) to Stage IV patients (dashed). D, Kaplan-Meier relapse-free survival curves comparing patients with irAE (dashed) to patients without irAE (solid). “o” indicates censored observations.